This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Review -
Androgenic regulation of novel genes in the epididymis
Bernard Robaire1,3, Shayesta
Seenundun1, Mahsa Hamzeh1, Sophie-Anne
Lamour1
1Department of Pharmacology and Therapeutics and
2Department of Obstetrics and Gynecology, McGill University,
Montréal, QC H3G1Y6, Canada
Abstract
The epididymis is critically dependent on the presence of the testis. Although several hormones, such as retinoids
and progestins, and factors secreted directly into the epididymal lumen, such as androgen binding protein and
fibroblast growth factor, might play regulatory roles in epididymal function, testosterone (T) and its metabolites,
dihydrotestosterone (DHT) and estradiol (E2), are accepted as the primary regulators of epididymal structure and
functions, with the former playing the greater role. To ascertain the molecular action of androgens on the epididymis,
three complementary approaches were pursued to monitor changes in gene expression in response to different
hormonal milieux. The first was to establish changes in gene expression along the epididymis as androgenic support is
withdrawn. The second was to determine the sequence of responses that occur in an androgen deprived tissue upon
re-administration of the two metabolites of T, DHT and E2. The third was to study the effects of androgen
withdrawal and re-administration on gene expression in immortalized murine caput epididymidal principal cells. Specific
responses were observed under each of these conditions, with an expected major difference in the panoply of genes
expressed upon hormone withdrawal and re-administration; however, some key common features were the common
roles of genes in insulin like growth factor/epidermal growth factor and the relatively minor and specific effects of E2
as compared to DHT. Together, these results provide novel insights into the mechanisms of androgen regulation in
epididymal principal cells. (Asian J Androl 2007 July; 9: 545_553)
Keywords: epididymis; cell culture; androgen withdrawal; dihydrotestosterone; estradiol; apoptosis; survivin; insulin like growth factor
Correspondence to: Dr Bernard Robaire, Department of Pharmacology and Therapeutics, 3655 Promenade Sir William Osler, Room 104,
Montréal, QC H3G1Y6, Canada.
Tel: +1-514-398-3630 Fax: +1-514-398-7120
E-mail: bernard.robaire@mcgill.ca
DOI: 10.1111/j.1745-7262.2007.00316.x
1 Introduction
As early as 1926, pioneering studies by Benoit [1] demonstrated that the epididymis was dependent on an
unknown testicular substance for maintenance of its structure and functions. This regulatory substance was identified
as testosterone (T) [2]; there have been numerous publications on the response of the epididymis in mammals to
androgen withdrawal (for review see [3]). Several lines of evidence have established that the active androgen in the
epididymis is not T, but its 5α-reduced metabolite, dihydrotestosterone (DHT) [3, 4]; hence, steroid
5α-reductase activity is a key regulator of androgen action in this tissue [3_5]. In addition to androgens, many other hormonal
factors have been postulated to play a role in regulating epididymal function [3, 6]. Of special note is estradiol (E2),
another metabolite of T. Administration of estrogens has major effects on the epididymis [7_9]. With the advent of
specific aromatase inhibitors and knockout mice for the two isoforms of the estrogen receptor, it has become possible
to resolve some of the functions regulated by E2 in the epididymis.
2 Androgen and estrogen receptors in the epididymis
The most prevalent androgen, T, is produced by the interstitial cells (Leydig cells) of the testis on an ongoing basis.
Concentrations of T in the seminiferous tubules are 10_100 times those found in serum [5, 10], and are essential for the
maintenance of spermatogenesis [11_13]. High
concentrations of T leave the testis through the efferent ducts and,
upon entry into the epididymis, are rapidly converted to
DHT [10], the most biologically active endogenous androgen, by the enzyme steroid
5α-reductase and to E2 by the P450 enzyme, steroid aromatase, which is
found in spermatozoa [14].
The actions of both T and DHT are primarily
mediated by binding to the androgen receptor (AR), although
there is some evidence for cell-surface mediated
androgen action [15, 16]. Androgen receptors are found in
the epididymis of all species examined to date (rat, rabbit,
dog, ram, monkey and human) (for review see [3]).
Although only a single AR gene (approximately 110 Kb)
has been identified, polymorphisms of this gene have been
reported [17_20]. There are small changes in the
concentrations of the mRNA for the AR along the
epididymis [21]; when these occur, they are usually coincident
with a small decline in the concentration of AR protein
down the epididymis [22]. In the rat and other species,
immunoreactivity to the AR is found throughout the duct,
primarily in principal cells [23], although other cell types
(basal and apical) also react [24, 25].
Clear evidence for the existence of estrogen
receptors (ER) in the epididymis of many species has existed
since the 1970s (for review see [3]). However, it is only
with the advent of highly specific antibodies and
knockout (KO) mice for the estrogen receptors, ERα and
ERβ, that proof of the presence of the receptors and the need
for E2 in the male excurrent duct system became
evident [26]. The immunolocalization of ERα and
ERβ along the efferent ducts and epididymis of the human
and rat reveals that ERα is primarily expressed in the
efferent ducts and the proximal end of the epididymis,
whereas ERβ is found along the entire tissue [23, 24, 26].
The ERα KO mouse [27] is infertile owing to back
pressure atrophy of the seminiferous tubules, which results
from the inability of the efferent ducts and initial
segment of the epididymis to re-absorb the large volume of
fluid secreted by the testis. In contrast to the clear role
of the ERα receptor, the function of ER in the
epididymis is unclear [28].
3 Effects of androgen withdrawal on the
epididymis
The main approach to understanding the effects of
androgen withdrawal on the epididymis has been removal
of the testes. Removing the testes, as the main source
of androgen and other testicular factors that have direct
input into the epididymis, serves to help resolve how the
epididymis is normally sustained; it also provides insight
into pathological conditions, such as hypogonadism [29],
and a better understanding of the consequences of male
aging (andropause), when androgen production shows a
marked decline [30]. It is clear that this approach causes
loss of not only androgens but also estrogens and any
other testicular factors that might affect the epididymis;
however, most of the effects of orchidectomy has been
ascribed to the precipitous fall in androgens [31, 32].
Orchidectomy causes a decrease in epididymal weight
that is less marked than that of sex accessory tissues,
such as the prostate or the seminal vesicles [33]. Unlike
other androgen-dependent male reproductive tissues, T
replacement in orchidectomized animals, even at
supra-physiological levels, only partially restores epididymal
weight; presumably, this is because of the large
proportion (nearly half) of epididymal weight that is attributable
to spermatozoa and the luminal fluid bathing them [33,
34]. In the androgen-deprived state, spermatozoa
become immotile, lose the ability to fertilize and die [35].
After orchidectomy, the epididymal luminal diameter and
epithelial cell height decrease and there is a relative
increase in the intertubular stroma [36]. The smooth
endoplasmic reticulum content is dramatically reduced,
whereas the extent of the decline in the Golgi apparatus
is less pronounced [36_38]. Morphological changes in
principal cells suggest that these cells are particularly
sensitive to androgen levels, in contrast to the other
epithelial cell types [39]. The secretory function of
principal cells becomes compromised in the androgen-deprived
state. Principal cells undergo a striking loss of apical
microvilli from their surface, as well as lysosome
accumulation, vacuolization, disappearance of vesicles
from the cell apex, and increased endocytosis [39].
Withdrawal of androgen by orchidectomy induces a
wave of apoptotic cell death in the epididymis, beginning
in the initial segment and moving over several days to the
cauda epididymidis [31, 40]. Apoptosis in the initial
segment seems to be caused by withdrawal of androgen and
of luminal components coming from the testis and is
p53-independent [31, 40]. Using the entire epididymis,
expression of Bcl-2, an anti-apoptotic factor [41], was
suppressed by orchidectomy, followed by the appearance of
Fas and DNA fragmentation, suggesting that regression
of the tissue might be regulated via the Fas pathway [42].
To gain a better appreciation of the range of effects
of androgen withdrawal on the epididymis, gene
expression profiling has been used in several studies [41, 43].
The first of these studies, showing changes in the
pattern of gene expression along the epididymis over the
first week after orchidectomy, was done in the rat [41]. A
transient upregulation in the expression of a select
family of genes along the epididymis was found. Several
androgen-repressed genes (e.g. glutathione
peroxidase-1 [Gpx-1]), showed increased expression in the
epididymis after orchidectomy, whereas transcripts for many
others (e.g. glutathione S-transferases and
calcium-binding proteins) declined throughout the epididymis after
orchidectomy. Other genes coding for
metabolism-associated proteins, transporters and alpha-1 acid
glycoprotein showed segment-specific regulation in the
epididymis after orchidectomy. The expression of several
previously uncharacterized heat shock proteins and
apoptosis-associated genes was also found to change
dramatically. Using the mouse, and observing changes
at only one fixed time point, Chauvin
et al. [43] confirm several of these findings.
To investigate the early response of apoptosis and
survival genes that was activated after withdrawal and/or
immediate supplementation of androgen in the different
regions of the epididymis, we used rat apoptosis-specific
arrays (ORN-012, SuperArray) that contained 96 genes.
Male Brown Norway rats were orchidectomized and treated with empty or T-filled implants designed to
maintain serum T at control concentrations. Rats were killed
shortly (12 h and 1 day) after orchidectomy and
epididymides were collected. The time-dependent and
region-dependent changes in gene expression on this array
are shown in Figure 1.
In all treatment groups, less than 16% of the genes
on the array showed a differential expression as
compared to the control. In the absence of T, 6_16% of the
genes were differentially expressed; the corpus and cauda
epididymidis were the regions most affected, at 12 h and
1 day, respectively. T maintenance partially prevented
differential expression of genes, with only 4_9% of the
genes remaining differentially expressed.
At 12 h without T, most of the genes affected
belonged to the tumor necrosis factor receptor (Tnfrsf)
and Bcl-2 families. In the initial segment, Tnfrsf11b and
Tnfrsf26 were downregulated, whereas all the other
Tnfrsf members were upregulated in the caput, corpus
and cauda epididymidis. No differentially expressed
Bcl-2 family members were seen in the cauda epididymidis,
whereas Bmf, Mcl-1 and Bcl2a1 were upregulated in the
initial segment and caput epididymidis. In the corpus,
Bcl-2, Bnip3, Bnip3l, Bad and Bok were all downregulated.
T supplementation prevented the differential expression
of all the Bcl-2 and Tnfrsf family members, except for
Bmf, Tnfrsf4 and Tnfrsf1b, which remained upregulated.
At day 1 without T, the initial segment showed no
genes differentially expressed, whereas Bad, Bnip3 and
Bnip3l were downregulated in the cauda epididymidis. No
additional Tnfrsf members were affected in the caput and
corpus regions, whereas Tnfrsf11b/osteoprotegerin
remained downregulated in the initial segment. In addition,
the inhibitor of apoptosis protein, Birc5/surviving, was
downregulated in all regions except the cauda, whereas all
regions except the caput showed an increased expression
of two repair proteins, Rad50 and Rad52. T
supplementation did not affect the pattern of differentially expressed
genes belonging to the Bcl-2 family. Furthermore,
Tnfrsf11b remained downregulated in the initial segment,
but became upregulated in the caput, whereas Birc5
became downregulated in the cauda.
These data, summarized in Figure 1, demonstrate that
there are rapid region-specific responses that result in
both selective upregulation and downregulation of
selected members of the Tnf and Bcl families. The
normally sustained repression of several genes associated
with apoptosis might account for the normal lack of cell
death seen in this tissue and the reported lack of
spontaneous carcinomas originating in the epididymis [44].
4 Effects of hormone replacement on the regressed
epididymis
Once the epididymis has regressed, administration
of T has the ability to dramatically restore most of the
histological features of the epithelium. Clearly, the lack
of spermatozoa and fluid prevents a return to control
organ weight [33]. Unlike the case with the prostate,
giving very high doses of T does not result in epithelial
hyperplasia [33]. Relatively few studies have examined
the sequence of events that occurs upon
re-administration of androgens once the epididymis has regressed.
We have found that after administration of DHT to rats
that had been orchidectomized for 1 week, no
significant increase in weight occurs at day 0.5 or 1, the first
significant increase is seen at 3 days, and by 7 days the
weight has nearly doubled; interestingly, E2
administration had no effect. Using orchidectomy and hormone
replacement after a one-week regression period, we
examined the actions of the two active metabolites of T,
DHT and E2, on the sequence of gene expression responses in the epididymis to resolve the molecular events
associated with androgen action in this tissue.
Using Affymetrix Rat Genome 230-2 Microarray chips containing 31 000 probe sets, gene expression
profile changes were observed in the initial segment and caput
of the regressed rat epididymides as early as 0.5, 1 and
7 days after replacement with either DHT or E2.
Differential expression was defined as those transcripts that
had a difference of twofold or greater in normalized
values and were statistically different (significance level set
at P < 0.05); microarray results for a selected subset of
genes were confirmed by reverse transcriptase polymerase chain reaction (RT-PCR).
Interestingly, of the 1 059 genes that were affected
by orchidectomy after 7 days, the expression of
approximately as many genes (546 genes) were upregulated as
were downregulated (513 genes). After treatment for
7 days with DHT, over 75% of the genes returned
toward the control, un-orchidectomized values. In contrast,
the expression of only 13 genes was altered by E2 treatment, and only 5 of these genes had been affected
by orchidectomy. Among genes affected by DHT replacement after androgen deprivation, many genes
belong to specific functional gene families. These include
solute carrier family (Slc12a3, Slc15a2, Slc22a5,
Slc9a2), cell communication (Gja1, Gja4,
Gjb3), cell growth, regulation of cell proliferation and apoptosis
(Ahr, Ar, Plau, Pdgfc, Figf), signal pathway and signal
transduction (Ramp3, Calcrl, Itpr3), proteolysis and peptidolysis
(Adam7, Adam9, Ctsc), and development (Acta1, Gas7,
Pppr2b2). We shall focus on three genes affected by
DHT and one by E2.
Placentae and embryos oncofetal gene
(Pem), a member of the homeobox factor family, is expressed in
Sertoli cell of the testis and in the epididymis, suggesting
that it plays an important role in sperm function [45].
Using transgenic mice that express Pem in Sertoli cell
during all stages of the seminiferous cycle,
Pem was shown to regulate the expression of Sertoli cell genes
that encode proteins that serve to control premeiotic DNA
replication, DNA repair and chromatin remodeling in the
adjacent germ cells [46]. Although androgens are
necessary but not sufficient for Pem expression in Sertoli
cells, we found that DHT was able to maintain the level
of Pem expression in the epididymis; the significant
decrease found after orchidectomy was reversed and
returned to the control level after replacement with DHT
for 1 day.
Protein phosphatase 2 (formerly 2A), regulatory
subunit B (PR 52), beta isoform (Ppp2r2b), regulates the
activity of the PP2A catalytic subunit in spermatids, and
is involved in spermatogenesis, especially spermatid
elongation [47]. Although the mRNA for this gene has been
shown to be expressed in the rat brain and testis, it has
not been looked at in the epididymis. We found that this
gene was highly upregulated after orchidectomy, and that
DHT suppressed its expression to control levels after
7 days.
Cysteine-rich secretory protein 1 (Crisp1), an
androgen-regulated secretory protein of the rat epididymis, binds
to the post-acrosomal region of the sperm head [48];
therefore, it is one of the sperm surface proteins thought to
be involved in the fusion of sperm and egg plasma membranes. We found that DHT treatment for 7 days
reversed the suppression of expression caused by
orchidectomy to the control levels.
Although the expression of many genes is affected
by DHT, few genes responded to E2. Chloride
intracellular channel 3 (LOC 296566) (Clic3) expression
significantly declined after orchidectomy; this change could be
reversed by E2 after 7 days. CLIC proteins have been
identified in bovine epididymal spermatozoa [49] and are
likely to play significant roles in sperm function.
Therefore, it is clear that an androgen-dependent
regressed tissue, such as the epididymis, mounts a robust,
rapid response after exposure to DHT by both upregulating
and downregulating a number of genes well before any
structural changes are apparent; the response to DHT is
far more dramatic than that of E2.
6 Changes in gene expression in immortalized mouse
caput epididymal principal cells in response to
androgen withdrawal and re-administration
Several pure epididymal cell lines have been
established recently [50_53]. The cell lines developed in the
Orgebin-Crist lab (PC-1, DC-1, DC-2 and DC-3) are the
first immortalized epithelial cell lines of the epididymis
that have been shown to display tissue and initial
segment/caput-specific gene expression [51]. They show a
similar polarity to principal cells in vivo in terms of their
distribution of cellular organelles, and retain the type of
junctional complexes seen between principal cells
in situ. They also express a number of principal cell markers
and are responsive to androgens.
To gain a comprehensive insight into gene expression
in following androgen withdrawal and supplementation,
we explored the androgen dependence of the PC-1
epididymal cell line by using DNA microarrays [54]. Changes
in gene expression occurring 2, 4 and 6 days after
androgen deprivation and 2 days after androgen
supplementation after being deprived of androgen for 2 or 4 days were
examined. Four distinct patterns of gene expression were
activated following androgen withdrawal; the vast
majority of genes displayed an early or late transient increase in
expression levels. A differential ability of rescue was seen
among androgen-regulated genes depending on the time
of androgen supplementation. Many of the genes that
were rescued at 4 days were functionally linked by
direct interactions and converged on insulin like growth
factor-1 (IGF-1). The ability for rescue after 4 days of
androgen deprivation was severely compromised in many
genes belonging to specific functional gene families (cell
adhesion, cell growth, apoptosis and cell cycle) and might
be mediated in part by changes in AR coregulator expression. Using a pathway analysis approach, a
common node of several of the affected genes was IGF-1
(Figure 2).
7 Potential role of the insulin like growth factor
gene (IGF) family and epidermal growth factor (EGF)
in mediating androgen action
The insulin-like growth factor network is composed
of IGF-1 and IGF-2, mitogenic peptides involved in the
regulation of cellular proliferation, differentiation and
apoptosis [55]. IGF have a structural homology with
pro-insulin, and are mainly produced by liver and bone
marrow [56]. Both IGF-1 and IGF-2 bind with high affinity
to the IGF-1 receptor, a tyrosine kinase located on the cell
membrane, and initiate mitogenic responses in cells [57,
58]; IGF exert anti-apoptotic and mitogenic effects in the
prostate [59]. Similarly, IGF-1 plays a crucial role in Leydig
cell maturation in the testis; null mutations for this growth
factor result in decreased levels of androgens, a poorly
developed epididymis, and infertility [60, 61].
A physiological role for IGF-1 in the regulation of
epididymal functions was hypothesized over 10 years ago as
judged by the varied immunohistochemical localization of
IGF-1 protein in the rat epididymis [62]. IGF-1R mRNA
and protein have also been localized in the epididymis [60,
63]. Adult mice with a homozygous null mutation of the
IGF-1 gene are infertile dwarfs with reduced T
production and, consequently, reduced spermatogenesis and
reproductive organ size [60]. Interestingly, the epididymal
phenotype of IGF-1 null mice is more severe in the distal
regions of the tissue, with greater reductions in weight
and decreased tubule coiling. We found that the
expression of IGF-1 and IGF-1R was highest in the distal
epididymal regions [64]. These results are consistent with a
role for IGF signaling in the distal regions of the
epididymis (corpus and cauda epididymidis). Further
corroborating this conclusion is the demonstration of the unique
effects of 5α-reductase inhibitor treatment on the
expression of IGF-1, and possibly IGF-1R, predominantly in the
corpus and cauda epididymidis [64].
IGF-binding proteins (IGFBP1-6) modulate the
availability of unbound IGF for interaction with IGF-1R [65].
IGFBP-3 is the most prevalent of the six IGFBPs [66].
More than 90% of circulating IGF is bound to IGFBP-3.
IGFBP-3 is known to impair IGF action and inhibit cell
growth, either by blocking free IGF or through an
IGF-independent mechanism [67]. IGF and IGFBP-3 play
important roles in prostate epithelial cell proliferation,
apoptosis and tumor progression [68]. In
silico analysis identified that a putative androgen response element in
the IGFBP-3 promoter and 10 nmol/L of DHT (a growth
inhibitory dose) can induce IGFBP-3 expression in LNCaP
cells [69]. We analyzed the epididymal expression of
two high-affinity IGF binding proteins, IGFBP-5 and
IGFBP-6. Again, these genes were more highly expressed
in the distal regions of the epididymis and were mainly
affected by 5α-reductase inhibitor treatment in these regions.
IGFBP-5 expression was particularly affected by treatment,
decreasing dramatically in the cauda epididymidis [64].
IGF-1 and EGF play synergistic critical roles in
pathological processes, such as carcinogenesis and wound
healing [70]. The presence of EGF [71] and EGF receptors
[72] in the testes of different species implicates their
central role in the regulation of spermatogenesis [71, 73].
It was shown that removal of the submaxillary gland, the
tissue that produces most EGF, results in a major loss of
spermatozoa from the epididymis that was
reversed by giving EGF; no effects on serum T or gonadotropins
were noted, implying a direct role of this growth factor
in regulating epididymal function [74]. Androgens
increase EGF binding sites in the rat prostate and modulate
the cellular proliferation of this tissue [75]; therefore,
suppression of EGF receptor signaling results in
reduction in the incidence of prostate cancer metastasis [76].
The EGF receptor in the epididymis of non-human
primates is located in both the basolateral and apical
borders of the epididymal epithelial cells [77]. Furthermore,
immunohistochemical studies on C3H mice have shown
that the intracellular localization of the EGF receptor varied
along the epididymis; the staining was more intense in
the cytoplasm of principal cells in the caput and in the
apical cytoplasm in the corpus and cauda regions [78].
The EGF gene is expressed in the mouse epididymis in a
segment-specific manner: low in the proximal region of
the caput and increasing in the corpus [79]. However,
immunolocalization of EGF, IGF-1, IGF-1R and IGFBP-3
in the adult rat epididymis has not been clearly established.
The underlying mechanisms regulating IGFBP-3 expression and its functional role in epididymal cell growth
remain to be elucidated. We speculate that EGF/IGF-1
interact intimately with androgens to regulate cell growth
and proliferation. By taking a series of complementary
approaches to understand how the action of T and its
metabolites are mediated, both when initially withdrawn
and re-administered to the epididymis, we have
identified several novel gene targets. Some of these genes are
likely to be early steroid hormone response genes and
might prove to be powerful targets for the development
of drugs that will regulate epididymal functions for
purposes of controlling male fertility.
Acknowledgment
These studies were supported by a grant from the
Canadian Institutes for Health Research.
References
1 Benoit J. Recherches anatomiques, cytologiques et
histophysiologiques sur les voies excrétrices du testicule chez les
mammifères. Arch Anat Histol Embryol (Strasb) 1926; 5:
173_412.
2 Butenandt A. Über die chemische Untersuchung der der
Sexualhormone. Z Angnew Chem 1931; 44: 905_8.
3 Robaire B, Hinton B, Orgebin-Crist MC. The Epididymis. In:
Knobil JN, editor. Physiology of Reproduction. New York:
Elsiever; 2006: 1071_148.
4 Robaire B, Viger RS. Regulation of epididymal epithelial functions.
Biol Reprod 1995; 52: 226_36.
5 Turner TT, Jones CE, Howards SS, Ewing LL, Zegeye B, Gunsalus
GL. On the androgen microenvironment of maturing
spermatozoa. Endocrinology 1984; 115: 1925_32.
6 Robaire B, Hermo L. Efferent ducts, epididymis and vas deferens:
structure, functions and their regulation. In: Knobil E, Neill J,
editors. Physiology of Reproduction. New York: Raven Press: 1988.
7 Meistrich ML, Hughes TH, Bruce WR. Alteration of epididymal
sperm transport and maturation in mice by oestrogen and
testosterone. Nature 1975; 258: 145_7.
8 Orgebin-Crist MC, Eller BC, Danzo BJ. The effects of estradiol,
tamoxifen, and testosterone on the weights and histology of the
epididymis and accessory sex organs of sexually immature rabbits.
Endocrinology 1983; 113: 1703_15.
9 Carreau S. Estrogens_male hormones? Folia Histochem Cytobiol
2003; 41: 107_11.
10 Turner TT. Spermatozoa are exposed to a complex
microenvironment as they traverse the epididymis. Ann N Y Acad Sci
1991; 637: 364_83.
11 Jarow JP, Zirkin BR. The androgen microenvironment of the
human testis and hormonal control of spermatogenesis. Ann N
Y Acad Sci 2005; 1061: 208_20.
12 Awoniyi CA, Sprando RL, Santulli R, Chandrashekar V, Ewing
LL, Zirkin BR. Restoration of spermatogenesis by exogenously
administered testosterone in rats made azoospermic by
hypophysectomy or withdrawal of luteinizing hormone alone.
Endocrinology 1990; 127: 177_84.
13 Coviello AD, Bremner WJ, Matsumoto AM, Herbst KL, Amory
JK, Anawalt BD, et al. Intratesticular testosterone
concentrations comparable with serum levels are not sufficient to maintain
normal sperm production in men receiving a hormonal
contraceptive regimen. J Androl 2004; 25: 931_8.
14 Janulis L, Bahr JM, Hess RA, Janssen S, Osawa Y, Bunick D. Rat
testicular germ cells and epididymal sperm contain active P450
aromatase. J Androl 1998; 19: 65_71.
15 Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris
CE, et al. Functional testosterone receptors in plasma
membranes of T cells. FASEB J 1999; 13: 123_33.
16 Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN,
Stournaras C, Castanas E. The human prostate cancer cell line
LNCaP bears functional membrane testosterone receptors that
increase PSA secretion and modify actin cytoskeleton. FASEB J
2002; 16: 1429_31.
17 Brown C, Goss S, Lubahn D, Joseph D, Wilson E, Frech F, Willard
HF. Androgen receptor locus on the human X chromosome:
regional localization to Xq11-12 and description of a DNA
polymorphism. Am J Hum Genet 1989; 44: 264_9.
18 Zhou ZX, Wong CI, Sar M, Wilson EM. The androgen receptor:
an overview. Recent Prog Horm Res 1994; 49: 249_74.
19 Ahrens-Fath I, Politz O, Geserick C, Haendler B. Androgen
receptor function is modulated by the tissue-specific AR45 variant.
FEBS J 2005; 72: 74_84.
20 Singh AS, Chau CH, Price DK, Figg WD. Mechanisms of disease:
polymorphisms of androgen regulatory genes in the
development of prostate cancer. Nat Clin Pract Urol 2005; 2: 101_7.
21 Robaire B, Viger RS. Regulation of epididymal epithelial functions.
In: Zirkin BR, Whitcomb R, editors. Understanding Male
Infertility: Basic and Clinical Approaches. New York: Raven
Press; 1993: 183_210.
22 Ungefroren H, Ivell R, Ergun S. Region-specific expression of
the androgen receptor in the human epididymis. Mol Hum Reprod
1997; 3: 933_40.
23 Goyal HO, Bartol FF, Wiley AA, Khalil MK, Chiu J, Vig MM.
Immunolocalization of androgen receptor and estrogen receptor
in the developing testis and excurrent ducts of goats. Anat Rec
1997; 249: 54_62.
24 Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS,
Hess RA. Localization of androgen and estrogen receptors in
adult male mouse reproductive tract. J Androl 2002; 23:
870_81.
25 Zhu LJ, Hardy MP, Inigo IV, Huhtaniemi I, Bardin CW,
Moo-Young AJ. Effects of androgen on androgen receptor expression
in rat testicular and epididymal cells: a quantitative
immunohistochemical study. Biol Reprod 2000; 63: 368_76.
26 Hess RA. The efferent ductules: structure and functions. In:
Robaire B, Hinton BT, editors. The Epididymis: From
Molecules to Clinical Practice. New York: Kluwer Academic/Plenum;
2002: 49_80.
27 Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS,
Smithies O. Alteration of reproductive function but not prenatal sexual
development after insertional disruption of the mouse estrogen
receptor gene. Proc Natl Acad Sci U S A 1993; 90: 11162_6.
28 Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF,
et al. Generation and reproductive phenotypes of mice lacking
estrogen receptor beta. Proc Natl Acad Sci U S A 1998; 95:
15677_82.
29 Grant NN, Anawalt BD. Male hypogonadism in the primary care
clinic. Prim Care 2003; 30: 743_63.
30 Tenover JS. Declining testicular function in aging men. Int J
Impot Res 2003; 15 (Suppl 4): S3_8.
31 Fan X, Robaire B. Orchidectomy induces a wave of apoptotic cell
death in the epididymis. Endocrinology 1998; 139: 2128_36.
32 Frank LA, Rohrbach BW, Bailey EM, West JR, Oliver JW.
Steroid hormone concentration profiles in healthy intact and
neutered dogs before and after cosyntropin administration. Domest
Anim Endocrinol 2003; 24: 43_57.
33 Robaire B, Ewing LL, Zirkin BR, Irby DC. Steroid
5α-reductase and 3α-hydroxysteroid dehydrogenase in the rat epididymis.
Endocrinology 1977; 101: 1379_90.
34 Brooks DE. Influence of androgens on the weights of the male
accessory reproductive organs and on the activities of
mitochondrial enzymes in the epididymis of the rat. J Endocrinol
1979; 82: 293_303.
35 Dyson ALMB, Orgebin-Crist MC. Effect of hypophysectomy,
castration and androgen replacement upon the fertilizing ability
of rat epididymal spermatozoa. Endocrinology 1973; 93:
391_402.
36 Moore HD, Bedford JM. The differential absorptive activity of
epithelial cells of the rat epididymis before and after castration.
Anat Rec 1979; 193: 313_28.
37 Bartsch G, Oberholzer M, Hollinger O, Weber J, Weber A, Rohr
PR. Stereology: a new and quantitative morphological method
to study epididymal function. Andrologia 1978; 10: 31_42.
38 Fawcett DW, Hoffer AP. Failure of exogenous androgen to
prevent regression of the initial segments of rat epididymis after
efferent duct ligation or orchidectomy. Biol Reprod 1979; 20:
162_81.
39 Moore HD, Bedford JM. Short-term effects of androgen
withdrawal on the structure of different epithelial cells in the rat
epididymis. Anat Rec 1979; 193: 293_311.
40 Turner TT, Riley TA. p53 independent, region-specific
epithelial apoptosis in induced in the rat epididymis by deprivation of
luminal factors. Mol Reprod Dev 1999; 53: 188_97.
41 Ezer N, Robaire B. Gene expression differentially regulated in
the epididymis after orchidectomy. Endocrinology 2003; 144:
975_88.
42 Suzuki A, Matsuzawa A, Iguchi T. Down regulation of Bcl-2 is
the first step on Fas-mediated apoptosis of male reproductive
tract. Oncogene 1996; 13: 31_7.
43 Chauvin TR, Griswold MD. Androgen-regulated genes in the
murine epididymis. Biol Reprod 2004; 71: 560_9.
44 Okazaki IJ, Pryor JL. Cancer of the epididymis. In: Robaire B,
Hinton BT, editors. The Epididymis: From Molecules to Clinical
Practice. New York: Kluwer Academic/Plenum; 2002: 555_62.
45 Sutton KA, Maiti S, Tribley WA, Lindsey JS, Meistrich ML,
Bucana CD, et al. Androgen regulation of the Pem homeodomain
gene in mice and rat Sertoli and epididymal cells. J Androl 1998;
19: 21_30.
46 Rao MK, Wayne CM, Meistrich ML, Wilkinson MF.
Pem homeobox gene promoter sequences that direct transcription in
a Sertoli cell-specific, stage-specific, and androgen-dependent
manner in the testis in vivo. Mol Endocrinol 2003; 17: 223_33.
47 Moriya M, Fujinaga K, Yazawa M, Katagiri C.
Immunohistochemical localization of the calcium/calmodulin-dependent
protein phosphatase, calcineurin, in the mouse testis: its unique
accumulation in spermatid nuclei. Cell Tissue Res 1995; 281:
273_81.
48 Cohen DJ, Ellerman DA, Busso D, Morgenfeld MM, Piazza AD,
Hayashi M, et al. Evidence that human epididymal protein ARP
plays a role in gamete fusion through complementary sites on
the surface of the human egg. Biol Reprod 2001; 65:1000_5.
49 Wistrom CA, Meizel S. Evidence suggesting involvement of a
unique human sperm steroid receptor/Cl- channel complex in the
progesterone-initiated acrosome reaction. Dev Biol 1993; 159:
679_90.
50 Telgmann R, Brosens JJ, Kappler-Hanno K, Ivell R, Kirchhoff C.
Epididymal epithelium immortalized by simian virus 40 large T
antigen: a model to study epididymal gene expression. Mol Hum
Reprod 2001; 7: 935_45.
51 Araki Y, Suzuki K, Matusik RJ, Obinata M, Orgebin-Crist MC.
Immortalized epididymal cell lines from transgenic mice
overexpressing temperature-sensitive simian virus 40 large
T-antigen gene. J Androl 2002; 23: 854_69.
52 Sipila P, Shariatmadari R, Huhtaniemi IT, Poutanen M.
Immortalization of epididymal epithelium in transgenic mice
expressing simian virus 40 T antigen: characterization of cell lines and
regulation of the polyoma enhancer activator 3. Endocrinology
2004; 145: 437_46.
53 Dufresne J, St-Pierre N, Viger RS, Hermo L, Cyr DG.
Characterization of a novel rat epididymal cell line to study epididymal
function. Endocrinology 2005 146: 4710_20.
54 Seenundun S, Robaire B. Time dependent rescue of gene
expression by androgens in the mouse proximal caput epididymidis
(PC-1) cell line after androgen withdrawal. Endocrinology 2007;
148: 173_88.
55 Baserga R, Prisco M, Hongo A. IGFs and cell growth. In: Rosenfeld
RG, Robert CT, editors. The IGF System: Molecular Biology,
Physiology, and Clinical Applications. Totowa: Human Press;
1999: 329_53.
56 Zapf J, Schmid C, Froesch ER. Biological and immunological
properties of insulin-like growth factors (IGF) I and II. Clin
Endocrinol Metab 13: 3_30.
57 Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA,
Ramasharma K, et al. Insulin-like growth factor-II (IGF-II): a
potential autocrine/paracrine growth factor for human breast
cancer acting via the IGF-I receptor. Mol Endocrinol 1989; 3:
1701_9.
58 Perdue JF, Lebon TR, Kato J, Hampton B, Fujita-Yamaguchi Y.
Binding specificities and transducing function of the different
molecular weight forms of insulin-like growth factor-2 on IGF-1
receptors. Endocrinology 1991; 129: 3101_8.
59 Torring N, Vinter-Jensen L, Pedersen SB, Sorensen FB, Flyvbjerg
A, Nexo E. Systemic administration of insulin-like growth
factor I (IGF-I) causes growth of the rat prostate. J Urol 1997; 158:
222_7.
60 Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR,
et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol
Endocrinol 1996; 10: 903_18.
61 Wang GM, O'Shaughnessy PJ, Chubb C, Robaire B, Hardy MP.
Effects of insulin-like growth factor I on steroidogenic enzyme
expression levels in mouse leydig cells. Endocrinology 2003;
144: 5058_64.
62 Leheup BP, Grignon G. Immunohistochemical localization of
insulin-like growth factor I (IGF-I) in the rat epididymis. J Androl
1993; 14: 159_63.
63 Antich M, Fabian E, Sarquella J, Bassas L. Effect of testicular
damage induced by cryptorchidism on insulin-like growth factor I
receptors in rat Sertoli cells. J Reprod Fertil 1995; 104: 267_75.
64 Henderson NA, Cooke GM, Robaire B. Region-specific
expression of androgen and growth factor pathway genes in the rat
epididymis and the effects of dual 5α-reductase inhibition. J
Endocrinol 2006; 190: 779_91.
65 Furstenberger G, Senn HJ. Insulin-like growth factors and cancer.
Lancet Oncol Rev 2002; 3: 298_302.
66 Ali O, Cohen P, Lee KW. Epidemiology and biology of
insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer
molecule. Horm Metab Res 2003; 35: 726_33.
67 Leroith D. The insulin-like growth factor system and cancer.
Cancer Lett 2003; 195: 127_37.
68 Huynh H, Alpert L, Alaoui-Jamali MA, Ng CY, Chan TW.
Co-administration of finasteride and the pure anti-oestrogen ICI
182,780 act synergistically in modulating the IGF system in rat
prostate. J Endocrinol 2001; 171: 109_18.
69 Peng L, Malloy PJ, Wang J, Feldman D. Growth inhibitory
concentrations of androgen up-regulate insulin-like growth
factor binding protein-3 expression via an androgen response
element in LNCaP human prostate cancer cells. Endocrinology
2006; 147: 4599_607.
70 Simmons JG, Hoyt EC, Westwick JK, Brenner DA, Pucilowska
JB, Lund PK. Insulin like growth factor-1 and epidermal growth
factor interact to regulate growth and gene expression in IEC-6
intestinal epithelial cells. Mol Endocrinol 1995; 9: 1157_65.
71 Byyny RL, Orth DN, Cohen S. Radioimmunoassay of epidermal
growth factor. Endocrinology 1972; 90: 1261_6.
72 Suarez-Quian CA, Nilinski W. Immunocytochemical
localization of the epidermal growth factor in the mouse testis. Biol
Reprod 1990; 43: 1087_97.
73 Elson SD, Browne CA, Thorburn GD. Identification of
epidermal growth factor-like activity in human male reproductive
tissues and fluids. J Clin Endocrinol Metab 1984; 58: 589_94.
74 Tsutsumi O, Kurachi H, Oka T. A physiological role of epidermal
growth factor in male reproductive function. Science 1986; 233:
975_7.
75 Traish AM, Wotiz HH. Prostatic epidermal growth factor
receptors and their regulation by androgens. Endocrinology 1987;
121: 1461_7.
76 Angelucci A, Gravina GL, Rucci N, Millimaggi D, Festuccia C,
Muzi P, et al. Suppression of EGF-R signaling reduces the
incidence of prostate cancer metastasis in nude mice. Endocr Relat
Cancer 2006; 13: 197_210.
77 Radhakrishnam B, Suarez-Quian CA. Characterization of
epidermal growth factor receptor (EGFR) in testis, epididymis and
vas deferens of non-human primates. J Reprod Fertil 1992; 96:
13_23.
78 Suarez-Quian CA, Oke BO, Radhakrishnam B. Relationship
between submandibular gland epidermal growth factor and
spermatogenesis in C3H mice. Tissue Cell 1994; 12: 285_98.
79 Tomsig JL, Turner TT. Growth factors and the epididymis. J
Androl 2006; 27: 348_58. |